Tu'uhevaha Kaitu'u-Lino

Has grant

University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

New diagnostics to predict preelampsia and fetal growth restriction

Open Date: 2019-01-01

Close Date: 2022-12-31

Grant: Close

Development of vinorelbine as a tablet based therapy to cure ectopic pregnancies

Open Date: 2017-01-01

Close Date: 2019-01-01

Grant: Close

New generation antiplatelet therapies to prevent preeclampsia

Open Date: 2017-01-01

Close Date: 2019-01-01

Grant: Close

From pathogenesis to therapeutics: targeting two signalling pathways as a therapeutic strategy to treat preeclampsia

Open Date: 2017-01-01

Close Date: 2019-01-01

Grant: Close

From pathogenesis to therapeutics: targeting two signalling pathways as a therapeutic strategy to treat preeclampsia

Open Date: 2017-01-01

Close Date: 2019-01-01

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Fiona Brownfoot

Senior lecturer

University of Melbourne

AUSTRALIA

View details

Teresa M. MacDonald

University of Melbourne

AUSTRALIA

View details

Natalie J Hannan

University of Melbourne

AUSTRALIA

View details

Navin Michael

Singapore Institute for Clinical Sciences

SINGAPORE

View details

Emerson Keenan

University of Melbourne

AUSTRALIA

View details

Amanda Henry

University of New South Wales

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tu'uhevaha Kaitu'u-Lino

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (13)

The association between circulating SIGLEC6 and preeclampsia: observational studies of seven cohorts

Placental Endocannabinoid System: Focus on Preeclampsia and Cannabis Use

Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia

Using the methylome to predict pre-eclampsia

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia

A disintegrin and metalloproteinase 12 (ADAM12) is reduced at 36 weeks’ gestation in pregnancies destined to deliver small for gestational age infants

Clinical tools and biomarkers to predict preeclampsia

Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial.

Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria.

Analysis of mitochondrial regulatory transcripts in publicly available datasets with validation in placentae from pre-term, post-term and fetal growth restriction pregnancies

Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsia

LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast

Maternal circulating SPINT1 is reduced in small-for-gestational age pregnancies at 26 weeks: Growing up in Singapore towards health outcomes (GUSTO) cohort study

Collaborators (6)

Fiona Brownfoot

Teresa M. MacDonald

Natalie J Hannan

Navin Michael

Emerson Keenan

Amanda Henry

Make your next move.